A new study from South Korea has found that a common type of diabetes medicine may offer an unexpected benefit: a lower risk ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...

More than 9.5 million people globally live with type 1 diabetes, and this figure is increasing rapidly everywhere, across all ...

In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...

Regulatory T cells, which help to dampen inflammation, are being used in clinical trials against ailments such as rheumatoid ...

Emerging clinical evidence supporting an immunomodulatory effect The use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in clinical practice has increased as the multisystem benefits of this ...

While nearly 40 million people in the US suffer from diabetes, some 8.7 million of them don’t even know they have the ...

Autoimmune diseases attack different parts of the body and decrease its ability to fight invaders, causing vulnerability to ...

Autoimmune vasculitis is a group of conditions that cause blood vessel inflammation. Examples include Kawasaki disease and giant cell arteritis. They develop as a result of an overreaction of your ...

Primary immunodeficiency (PI) not only increases your risk of frequent and serious infections, but can also make you more likely to develop autoimmune diseases — conditions where the immune system ...

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed symptom of autoimmune diseases? Hair loss. Your immune system is meant to keep ...